Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N. Shenoy S, et al. Among authors: andreansky m. Blood. 2016 Nov 24;128(21):2561-2567. doi: 10.1182/blood-2016-05-715870. Epub 2016 Sep 13. Blood. 2016. PMID: 27625358 Free PMC article. Clinical Trial.
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease.
Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, Katsanis E, Lewis VA, Sahdev I, Orchard PJ. Lund TC, et al. Among authors: andreansky m. Biol Blood Marrow Transplant. 2014 Nov;20(11):1847-51. doi: 10.1016/j.bbmt.2014.06.019. Epub 2014 Jul 10. Biol Blood Marrow Transplant. 2014. PMID: 25016194 Free PMC article.
One-unit versus two-unit cord-blood transplantation for hematologic cancers.
Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J; Blood and Marrow Transplant Clinical Trials Network. Wagner JE Jr, et al. N Engl J Med. 2014 Oct 30;371(18):1685-94. doi: 10.1056/NEJMoa1405584. N Engl J Med. 2014. PMID: 25354103 Free PMC article. Clinical Trial.
Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.
King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, Jain A, Krajewski J, Gillio A, Kasow KA, Delgado D, Hanson E, Murray L, Shenoy S. King AA, et al. Among authors: andreansky m. Am J Hematol. 2015 Dec;90(12):1093-8. doi: 10.1002/ajh.24183. Epub 2015 Oct 6. Am J Hematol. 2015. PMID: 26348869 Free article.
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
Shenoy S, Walters MC, Ngwube A, Soni S, Jacobsohn D, Chaudhury S, Grimley M, Chan K, Haight A, Kasow KA, Parikh S, Andreansky M, Connelly J, Delgado D, Godder K, Hale G, Nieder M, Pulsipher MA, Trachtenberg F, Neufeld E, Kwiatkowski JL, Thompson AA. Shenoy S, et al. Among authors: andreansky m. Biol Blood Marrow Transplant. 2018 Jun;24(6):1216-1222. doi: 10.1016/j.bbmt.2018.01.023. Epub 2018 Jan 31. Biol Blood Marrow Transplant. 2018. PMID: 29374585 Free PMC article. Clinical Trial.
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
Bhatt ST, Bednarski JJ, Berg J, Trinkaus K, Murray L, Hayashi R, Schulz G, Hente M, Grimley M, Chan KW, Kamani N, Jacobsohn D, Nieder M, Hale G, Yu L, Adams R, Dalal J, Pulsipher MA, Haut P, Chaudhury S, Davis J, Jaroscak J, Andreansky M, Willert J, Shenoy S. Bhatt ST, et al. Among authors: andreansky m. Biol Blood Marrow Transplant. 2019 Mar;25(3):556-561. doi: 10.1016/j.bbmt.2018.10.008. Epub 2018 Oct 12. Biol Blood Marrow Transplant. 2019. PMID: 30321596 Free article. Clinical Trial.
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
Shah NC, Bhoopatiraju S, Abraham A, Anderson E, Andreansky M, Bhatia M, Chaudhury S, Cuvelier GDE, Godder K, Grimley M, Hale G, Kamani N, Jacobsohn D, Ngwube A, Gilman AL, Skiles J, Yu LC, Shenoy S. Shah NC, et al. Among authors: andreansky m. Transplant Cell Ther. 2022 Mar;28(3):174.e1-174.e5. doi: 10.1016/j.jtct.2021.12.016. Epub 2021 Dec 24. Transplant Cell Ther. 2022. PMID: 34958973 Free article. Clinical Trial.
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Eapen M, Kou J, Andreansky M, Bhatia M, Brochstein J, Chaudhury S, Haight AE, Haines H, Jacobsohn D, Jaroscak J, Kasow KA, Krishnamurti L, Levine JE, Leung K, Margolis D, Yu LC, Horowitz MM, Kamani N, Walters MC, Shenoy S. Eapen M, et al. Among authors: andreansky m. Am J Hematol. 2024 Apr;99(4):785-788. doi: 10.1002/ajh.27251. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343182 No abstract available.
26 results